findmyKOL
Clinical trialNCT01401647CompletedPhase 3Interventional

Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia

SponsorUniversity of WashingtonEnrollment3,024Cardiac Arrest
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of the trial is to determine if survival to hospital discharge is improved with early therapeutic administration of a new Captisol-Enabled formulation of IV amiodarone (Nexterone-PM101) compared to placebo.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Ottawa/university of British Columbia Collaborative Rcc, Ottawa Health Research

    Ottawa, Ontario, Canada

  • Toronto Regional Resuscitation Research Out-of-Hospital Network, University of Toronto

    Toronto, Ontario, Canada

United States
  • Alabama Resuscitation Center

    Birmingham, Alabama, United States

  • Ucsd-San Diego Resuscitation Center

    San Diego, California, United States

  • Portland Resuscitation Outcomes Consortium, Oregon Health & Sciences University

    Portland, Oregon, United States

  • the Pittsburgh Resuscitation Network, University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Dallas Center for Resuscitation Research, University of Texas Southwestern Medical Center

    Dallas, Texas, United States

  • Seattle-King County Center for Resuscitation Research, University of Washington

    Seattle, Washington, United States

  • Milwaukee Resuscitation Network, Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2012
Primary completion
31 Dec 2015
Completion
31 Jan 2016
Last update posted
17 Apr 2017
Registered enrollment
3,024
Registry id
NCT01401647

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.